Norixa Mini Tablet
NDC Package 84460-910-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Norixa Mini tablets is floravite Mini is a prescription multivitamin/multi-mineral dietary supplement formulated for the clinical dietary management of a suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed. This formulation utilizes a tablet delivery system. Marketed by Florrax Pharmaceutical, this product is identified by NDC 84460-910.

Identification & Billing

NDC Package Code
84460-910-30
Package Description
30 TABLET in 1 BOTTLE
Product Code
84460-910
11-Digit Billing Format
84460091030

Clinical Specifications

Proprietary Name
Norixa Mini
Non-Proprietary Name
Norixa Mini
Substance Name
Ascorbic Acid; Cholecalciferol; Cyanocobalamin; Ferrous Fumarate; Folic Acid; Thiamine; Vitamin A
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Floravite Mini is a prescription multivitamin/multi-mineral dietary supplement formulated for the clinical dietary management of a suboptimal nutritional status in patients where advanced folate, vitamin B supplementation, and maintenance of good health is needed.

Regulatory & Marketing

Labeler Name
Florrax Pharmaceutical
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
04-28-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84460-910-30 identifies a specific commercial package of 30 tablet in 1 bottle of Norixa Mini, a human prescription drug labeled by Florrax Pharmaceutical. This tablet is formulated for oral use and contains ascorbic acid; cholecalciferol; cyanocobalamin; ferrous fumarate; folic acid; thiamine; vitamin a as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Florrax Pharmaceutical on April 28, 2026. The current certification is valid through December 31, 2027.

How is this Florrax Pharmaceutical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84460091030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84460-910-30
11-Digit CMS (5-4-2)
84460-0910-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.